Skip to main

Designation of Eltrombopag (Revolade) as an orphan drug - GlaxoSmithKline

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2014G0122924 July 2014

Legislation text